10 reports

  • Sep 18, 2017: TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01
  • TF-0023 - DRUG PROFILE

" If you' ve just had a heart attack, the one thing the heart doesn' t need is to be told to work harder.

  • Cardiovascular Disease
  • Heart Attack
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • TF-0023 - DRUG PROFILE
  • THR-100 - DRUG PROFILE

Second, resolvin D-## was able to calm the microRNA storm that develops in heart-attack tissue, and it accelerated production of regenerative microRNAs in the resolving phase after the heart attack.

  • Cardiovascular Disease
  • Heart Attack
  • Pharmaceutical
  • Therapy
  • Product Initiative

SCAD is the number one cause of heart attacks in young women## and the average age is ##.

  • Heart Attack
  • Heart Failure
  • United States
  • Product Initiative
  • Abiomed, Inc.

(Inactive) ## ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## Abbott Laboratories Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2018 2018 trials are taken as of December 2018 ##

  • Heart Attack
  • Hospital
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cardiovascular Disease
  • Heart Attack
  • World
  • Product Initiative
  • Aurobindo Pharma Limited

THE MIRACOR PICSO® IMPULSE SYSTEM IS DESIGNED TO TREAT ACUTE HEART ATTACK STEMI PATIENTS AND LESS SEVERE NSTEMI HEART ATTACK PATIENTS IN COMPLEMENT WITH PERCUTANEOUS CORONARY INTERVENTION (PCI, OR CORONARY ANGIOPLASTY).

  • Heart Attack
  • United Kingdom
  • United States
  • Product Initiative
  • NSTEMI group

## ## ## ## ## ## Pfizer Inc Stealth BioTherapeutics Inc Prolong Pharmaceuticals LLC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Minapharm Pharmaceuticals & Chemical Industries ## ## ## ## ## ## ## Merck & Co Inc ## ##

  • Clinical Trial
  • Heart Attack
  • Pharmaceutical
  • Therapy
  • Product Initiative

RESEARCH INTO CICLOMULSION S EFFICACY BEYOND THE TREATMENT OF REPERFUSION INJURY FOLLOWING HEART ATTACK GREW OUT OF THE CONCEPT OF MITOCHONDRIAL PROTECTION IN CONNECTION WITH ORGAN INJURY FOCUSING ON HEART DISEASE.

  • Heart Attack
  • Therapy
  • World
  • Product Initiative
  • CicloMulsion AG

They are coming in with a heart attack.

  • Heart Attack
  • Therapy
  • United States
  • Product Initiative
  • Abbott Vascular, Inc.

At the heart of Vereos is a state-of-the-art detector that converts detected photons directly into digital information.

  • Diagnostic Imaging
  • Healthcare
  • Heart Attack
  • Magnetic Resonance Imaging
  • Product Initiative